An artificial intelligence program called a neural network exceeds radiologists’ ability to detect malignancies, but more testing is needed before using the program clinically.

Delivery guidelines should be updated to reflect these results, the authors write.

Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.

Although the oral treatment seems to work, an analysis of the results from 12 clinical trials finds kids who got an immunotherapy have a greater rate of serious reactions.

An early-stage clinical study finds that none of the 25 patients treated developed neurotoxicity or cytokine release syndrome, common hazards of the cancer immunotherapy.

Computational biologist Jinghui Zhang of St. Jude realized scientists could work more efficiently with tools and genomic data shared on the cloud.

At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.

An artificially intelligent program tracks the motion of infants to help doctors look for links to disorders with abnormal motions.

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.